Astellas Pharma reported 32.63B in EBIT for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ebit Change
Astellas Pharma 4503:JP 32.63B 44.87B
Chugai Pharma 4519:JP 99.94B 87.07B
Daiichi Sankyo 4568:JP 34.38B 85.13B
Eisai 4523:JP 7.43B 28.23B
Kyowa Hakko Kirin 4151:JP 20.78B 4.67B
M3 2413:JP 18.51B 5.9B
Otsuka Holdings 4578:JP 46.55B 4.31B
Shionogi 4507:JP 12.42B 37.47B
Sumitomo Dainippon 4506:JP 14.61B 12.67B
Takeda 4502:JP 150.52B 152.13B
Terumo 4543:JP 30.43B 8.92B